JS

Jyotiben Subhashkumar Mehta

Active Director Director DIN 11198377
DIN 11198377 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyotiben Subhashkumar Mehta

Data last updated:

Jyotiben Subhashkumar Mehta is a Director at Truviska Pharmaceutical Private Limited (since 2025).

DIN 11198377
Primary Designation Director
First Appointment 17 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20252025Active

Board colleagues of Jyotiben Subhashkumar Mehta

Directorship timeline

Open interactive timeline →
Truviska Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jyotiben Subhashkumar Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyotiben Subhashkumar Mehta

Jyotiben Subhashkumar Mehta currently holds 1 directorship: Truviska Pharmaceutical Private Limited (Director, since 17 Jul 2025).

Jyotiben Subhashkumar Mehta was first appointed on 17 Jul 2025 as Director at Truviska Pharmaceutical Private Limited.

The current boards of Jyotiben Subhashkumar Mehta's companies include Dinesh Jabalsinh Bhati (Truviska Pharmaceutical Private Limited), Subhashkumar Mehta (Truviska Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available